URMC-099

Overview

URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 ( MLK3 ) ( IC 50 =14 nM) inhibitor with with excellent blood-brain barrier penetration properties.

Application

Products | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Obesity | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Mixed Lineage Kinase | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-12599
• CAS No.: 1229582-33-5
• Molecular Formula: C27H27N5
• Molecular Weight: 421.54
• Purity: 98.69%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.87 mg/mL (6.81 mM); Clear solution
• Availability: In-stock

Source

Original product source